Inventor · disambiguated record
Garth Whiteside
Also filed as: WHITESIDE GARTH · WHITESIDE GARTH T
18 granted patents·11 pending applications·47 citations·filing 2006–2024
93Inventor score
Top patents by PatentIndex Score
29 records- 0194US8946253B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2013·Granted Feb 3, 2015·23 cites·78 claims
- 0292US11738023B2Treatment and prevention of sleep disordersPURDUE PHARMA LP·Filed 2021·Granted Aug 29, 2023·2 cites·20 claims
- 0385US9872856B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2015·Granted Jan 23, 2018·3 cites·28 claims
- 0485US9849124B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2015·Granted Dec 26, 2017·2 cites·16 claims
- 0583US11576913B2Sleep disorder treatment and preventionPURDUE PHARMA LP·Filed 2019·Granted Feb 14, 2023·1 cites·16 claims
- 0682US12370191B2Treatment and prevention of sleep disordersPURDUE PHARMA LP·Filed 2023·Granted Jul 29, 2025·0 cites·20 claims
- 0782US9867817B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2015·Granted Jan 16, 2018·2 cites·24 claims
- 0882US9855262B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2015·Granted Jan 2, 2018·2 cites·24 claims
- 0982US9662326B2Systems for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2015·Granted May 30, 2017·2 cites·32 claims
- 1081US10974081B2Treatment and prevention of sleep disordersPURDUE PHARMA LP·Filed 2017·Granted Apr 13, 2021·2 cites·20 claims
- 1181US10226457B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2017·Granted Mar 12, 2019·1 cites·20 claims
- 1280US2025134886A1Sleep disorder treatment and preventionPURDUE PHARMA LP·Filed 2024·Application pending·0 cites
- 1379US12171762B2Sleep disorder treatment and preventionPURDUE PHARMA LP·Filed 2023·Granted Dec 24, 2024·0 cites·15 claims
- 1479US10398690B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2017·Granted Sep 3, 2019·1 cites·18 claims
- 1577US9763955B2Methods and compositions for decreasing gastric emptyingPURDUE PHARMA LP·Filed 2016·Granted Sep 19, 2017·3 cites·11 claims
- 1677US2021196706A1Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic ResponsePURDUE PHARMA LP·Filed 2021·Application pending·0 cites
- 1777US2020155542A1Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic ResponsePURDUE PHARMA LP·Filed 2019·Application pending·0 cites
- 1876US9931337B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2014·Granted Apr 3, 2018·2 cites·33 claims
- 1975US9884059B2Systems and methods for treating an opioid-induced adverse pharmacodynamic responsePURDUE PHARMA LP·Filed 2015·Granted Feb 6, 2018·1 cites·24 claims
- 2070US2024408078A1Method of treatment and dosage forms thereofPURDUE PHARMA LP·Filed 2024·Application pending·0 cites
- 2167US2022280527A1Trace amine associated receptor 1 agonists and partial agonists for pain treatmentPURDUE PHARMA LP·Filed 2022·Application pending·0 cites
- 2264US2025381180A1Methods of treating or preventing overactive bladder syndromePURDUE PHARMA LP·Filed 2023·Application pending·0 cites
- 2359US2024269133A1Methods of treating interstitial cystitis/bladder pain syndromePURDUE PHARMA LP·Filed 2022·Application pending·0 cites
- 2458US2020276187A1Systems and methods for attenuating opioid-induced euphoriaPURDUE PHARMA LP·Filed 2020·Application pending·0 cites
- 2556US12201629B2Method of treatment and dosage forms thereofPURDUE PHARMA LP·Filed 2018·Granted Jan 21, 2025·0 cites·14 claims
- 2656US2019201410A1Trace amine associated receptor 1 agonists and partial agonists for pain treatmentPURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 2751US2016074387A1Systems and Methods for Attenuating Opioid-Induced EuphoriaPURDUE PHARMA LP·Filed 2015·Application pending·0 cites
- 2846US10143696B2Methods and compositions for decreasing gastric emptyingPURDUE PHARMA LP·Filed 2017·Granted Dec 4, 2018·0 cites·10 claims
- 2944US2007015828A1Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereofWYETH CORP·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Garth Whiteside files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →